179 related articles for article (PubMed ID: 16052911)
1. Combining neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient.
Karlsson J; Petersén A; Gidö G; Wieloch T; Brundin P
Cell Transplant; 2005; 14(5):301-9. PubMed ID: 16052911
[TBL] [Abstract][Full Text] [Related]
2. Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons.
Hansson O; Castilho RF; Kaminski Schierle GS; Karlsson J; Nicotera P; Leist M; Brundin P
Exp Neurol; 2000 Jul; 164(1):102-11. PubMed ID: 10877920
[TBL] [Abstract][Full Text] [Related]
3. Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatum.
Sautter J; Höglinger GU; Oertel WH; Earl CD
Exp Neurol; 2000 Jul; 164(1):121-9. PubMed ID: 10877922
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural characterization of dissociated embryonic ventral mesencephalic tissue treated with neuroprotectants.
Ahn YH; Emgård M; Brundin P
Cell Transplant; 2003; 12(3):235-41. PubMed ID: 12797378
[TBL] [Abstract][Full Text] [Related]
5. Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspensions, cultures and transplants.
Karlsson J; Emgård M; Brundin P
Brain Res; 2002 Nov; 955(1-2):268-80. PubMed ID: 12419547
[TBL] [Abstract][Full Text] [Related]
6. Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro.
Othberg A; Keep M; Brundin P; Lindvall O
Exp Neurol; 1997 Oct; 147(2):498-502. PubMed ID: 9344573
[TBL] [Abstract][Full Text] [Related]
7. Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor.
Petersen A; Hansson O; Emgård M; Brundin P
Cell Transplant; 2000; 9(5):577-84. PubMed ID: 11144955
[TBL] [Abstract][Full Text] [Related]
8. Reassessment of caspase inhibition to augment grafted dopamine neuron survival.
Marchionini DM; Collier TJ; Pitzer MR; Sortwell CE
Cell Transplant; 2004; 13(3):273-82. PubMed ID: 15191165
[TBL] [Abstract][Full Text] [Related]
9. Caspase inhibition increases embryonic striatal graft survival.
Mundt-Petersen U; Petersén A; Emgård M; Dunnett SB; Brundin P
Exp Neurol; 2000 Jul; 164(1):112-20. PubMed ID: 10877921
[TBL] [Abstract][Full Text] [Related]
10. Tirilazad mesylate increases dopaminergic neuronal survival in the in Oculo grafting model.
Björklund L; Spenger C; Strömberg I
Exp Neurol; 1997 Nov; 148(1):324-33. PubMed ID: 9398475
[TBL] [Abstract][Full Text] [Related]
11. Caspase inhibition reduces apoptosis and increases survival of nigral transplants.
Schierle GS; Hansson O; Leist M; Nicotera P; Widner H; Brundin P
Nat Med; 1999 Jan; 5(1):97-100. PubMed ID: 9883846
[TBL] [Abstract][Full Text] [Related]
12. Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.
Hurelbrink CB; Armstrong RJ; Luheshi LM; Dunnett SB; Rosser AE; Barker RA
Exp Neurol; 2001 Sep; 171(1):46-58. PubMed ID: 11520120
[TBL] [Abstract][Full Text] [Related]
13. Combined inhibition of apoptosis and complement improves neural graft survival of embryonic rat and porcine mesencephalon in the rat brain.
Cicchetti F; Costantini L; Belizaire R; Burton W; Isacson O; Fodor W
Exp Neurol; 2002 Oct; 177(2):376-84. PubMed ID: 12429184
[TBL] [Abstract][Full Text] [Related]
14. Increased survival of embryonic nigral neurons when grafted to hypothermic rats.
Karlsson J; Emgård M; Gidö G; Wieloch T; Brundin P
Neuroreport; 2000 Jun; 11(8):1665-8. PubMed ID: 10852221
[TBL] [Abstract][Full Text] [Related]
15. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.
Brundin P; Pogarell O; Hagell P; Piccini P; Widner H; Schrag A; Kupsch A; Crabb L; Odin P; Gustavii B; Björklund A; Brooks DJ; Marsden CD; Oertel WH; Quinn NP; Rehncrona S; Lindvall O
Brain; 2000 Jul; 123 ( Pt 7)():1380-90. PubMed ID: 10869050
[TBL] [Abstract][Full Text] [Related]
16. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
[TBL] [Abstract][Full Text] [Related]
17. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.
Sortwell CE; Camargo MD; Pitzer MR; Gyawali S; Collier TJ
Exp Neurol; 2001 May; 169(1):23-9. PubMed ID: 11312554
[TBL] [Abstract][Full Text] [Related]
18. MK-801 does not enhance dopaminergic cell survival in embryonic nigral grafts.
Schierle GS; Karlsson J; Brundin P
Neuroreport; 1998 May; 9(7):1313-6. PubMed ID: 9631420
[TBL] [Abstract][Full Text] [Related]
19. An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.
Sortwell CE; Collier TJ; Camargo MD; Pitzer MR
Exp Neurol; 2004 May; 187(1):58-64. PubMed ID: 15081588
[TBL] [Abstract][Full Text] [Related]
20. FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons.
Castilho RF; Hansson O; Brundin P
Exp Neurol; 2000 Jul; 164(1):94-101. PubMed ID: 10877919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
